Roxanna S. Linden-Korologou
Oakfield Grove
Bristol, ENG, United Kingdom
Bristol, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Redefining ALS: Large-scale proteomic profiling reveals a prolonged pre-diagnostic phase with immune, muscular, metabolic, and brain involvement.
Journal: Research square
Published: September 15, 2025
Redefining ALS: Large-scale proteomic profiling reveals a prolonged pre-diagnostic phase with immune, muscular, metabolic, and brain involvement.
Journal: medRxiv : the preprint server for health sciences
Published: September 05, 2025
Large-scale plasma proteomics uncovers preclinical molecular signatures of Parkinson's disease and overlap with other neurodegenerative disorders.
Journal: medRxiv : the preprint server for health sciences
Published: August 06, 2025
The Global Neurodegeneration Proteomics Consortium: biomarker and drug target discovery for common neurodegenerative diseases and aging.
Journal: Nature medicine
Published: April 24, 2025
Preparing the way for novel blood-based biomarkers and disease-modifying treatments for Alzheimer's disease in the NHS in the UK.
Journal: Journal of the Royal Society of Medicine
Published: January 28, 2025
Novel Blood-Based Biomarkers and Disease Modifying Therapies for Alzheimer's Disease. Are We Ready for the New Era?
Journal: The journal of prevention of Alzheimer's disease
Published: July 24, 2024
The bidirectional effects between cognitive ability and brain morphology: A life course Mendelian randomization analysis.
Journal: medRxiv : the preprint server for health sciences
Published: November 28, 2023
Life course plasma metabolomic signatures of genetic liability to Alzheimer's disease.
Journal: Scientific reports
Published: November 13, 2023
Genetics impact risk of Alzheimer's disease through mechanisms modulating structural brain morphology in late life.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: November 09, 2023
Dementia prevention: the Mendelian randomisation perspective.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: July 24, 2023
Causal effects of circulating cytokine concentrations on risk of Alzheimer's disease and cognitive function.
Journal: Brain, behavior, and immunity
Published: February 14, 2022
Evaluating the efficacy and mechanism of metformin targets on reducing Alzheimer's disease risk in the general population: a Mendelian randomisation study.
Journal: Diabetologia
Published: January 03, 2022
Last Updated: 09/26/2026